Use of Skeletal Muscle MRI in Diagnosis and Monitoring Disease Progression in Duchenne Muscular Dystrophy

Physical Medicine and Rehabilitation Clinics of North America

Volumn 23, Issue 1, 2012, Pages 1-10

  Finanger, Erika L ^a,b,c   Russman, Barry ^a,b,c   Forbes, Sean C ^d   Rooney, William D ^e   Walter, Glenn A ^d   Vandenborne, Krista ^d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c SHRINERS HOSPITAL FOR CHILDREN   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Duchenne muscular dystrophy; MRI; Skeletal muscle

Indexed keywords

BIOLOGICAL MARKER; DYSTROPHIN; GADOLINIUM; GLUCOCORTICOID; MYOSTATIN; NEUTRALIZING ANTIBODY;

CLINICAL FEATURE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRUG RESPONSE; DUCHENNE MUSCULAR DYSTROPHY; DYSTROPHIN GENE; ECHOGRAPHY; ELECTRON SPIN RESONANCE; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HUMAN; IMAGE DISPLAY; IMAGE PROCESSING; INTERMETHOD COMPARISON; MUSCLE BIOPSY; MUTATOR GENE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RELAXATION TIME; REVIEW; VOXEL BASED MORPHOMETRY;

BIOLOGICAL MARKERS; CONTRAST MEDIA; DISEASE PROGRESSION; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE;

EID: 84855744036     PISSN: 10479651     EISSN: 15581381     Source Type: Journal    
DOI: 10.1016/j.pmr.2011.11.004     Document Type: Review

References (40)

1. Heckmatt J.Z., Dubowitz V., Leeman S. Detection of pathological change in dystrophic muscle with B-scan ultrasound imaging. Lancet 1980, 1(8183):1389-1390.
2. Heckmatt J.Z., Leeman S., Dubowitz V. Ultrasound imaging in the diagnosis of muscle disease. JPediatr 1982, 101(5):656-660.
3. Mercuri E., Pichiecchio A., Allsop J., et al. Muscle MRI in inherited neuromuscular disorders: past, present, and future. JMagn Reson Imaging 2007, 25(2):433-440.
4. Prompers J.J., Jeneson J.A., Drost M.R., et al. Dynamic MRS and MRI of skeletal muscle function and biomechanics. NMR Biomed 2006, 19(7):927-953.
5. Emery A.E. The muscular dystrophies. Lancet 2002, 359(9307):687-695.
6. Hoffman E.P., Brown R.H. Jr, Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987, 51(6):919-928.
7. Watkins S.C., Hoffman E.P., Slayter H.S., et al. Immunoelectron microscopic localization of dystrophin in myofibres. Nature 1988, 333(6176):863-866.
8. Petrof B.J., Shrager J.B., Stedman H.H., et al. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA 1993, 90(8):3710-3714.
9. Dubowitz V. Muscle disorders in children. 2nd edition. Kidlington (UK): Bailliere Tindall; 1995.
10. Moxley R.T.I.I.I., Ashwal S., Pandya S., et al. Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the quality standards subcommittee of the American Academy of Neurology and the practice committee of the Child Neurology Society. Neurology 2005, 64(1):13-20.
11. Angelini C. The role of corticosteroids in muscular dystrophy: a critical appraisal. Muscle Nerve 2007, 36(4):424-435.
12. Manzur A.Y., Kuntzer T., Pike M., et al. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst Rev (Online) 2008, 1. CD003725.
13. Markham L.W., Spicer R.L., Khoury P.R., et al. Steroid therapy and cardiac function in Duchenne muscular dystrophy. Pediatr Cardiol 2005, 26(6):768-771.
14. Kissel J.T., Burrow K.L., Rammohan K.W., et al. Mononuclear cell analysis of muscle biopsies in prednisone-treated and untreated Duchenne muscular dystrophy. CIDD study group. Neurology 1991, 41(5):667-672.
15. Griggs R.C., Moxley R.T.I.I.I., Mendell J.R., et al. Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months). Neurology 1993, 43(3 Pt 1):520-527.
16. Huang Y., Majumdar S., Genant H.K., et al. Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular dystrophy. JMagn Reson Imaging 1994, 4(1):59-64.
17. Kuriyama M., Hayakawa K., Konishi Y., et al. MR imaging of myopathy. Comput Med Imaging Graphv 1989, 13(4):329-333.
18. Marden F.A., Connolly A.M., Siegel M.J., et al. Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging. Skeletal Radiol 2005, 34(3):140-148.
19. Matsumura K., Nakano I., Fukuda N., et al. Duchenne muscular dystrophy carriers. Proton spin-lattice relaxation times of skeletal muscles on magnetic resonance imaging. Neuroradiology 1989, 31(5):373-376.
20. Matsumura K., Nakano I., Fukuda N., et al. Proton spin-lattice relaxation time of Duchenne dystrophy skeletal muscle by magnetic resonance imaging. Muscle Nerve 1988, 11(2):97-102.
21. Sookhoo S., Mackinnon I., Bushby K., et al. MRI for the demonstration of subclinical muscle involvement in muscular dystrophy. Clin Radiol 2007, 62(2):160-165.
22. Mercuri E., Talim B., Moghadaszadeh B., et al. Clinical and imaging findings in six cases of congenital muscular dystrophy with rigid spine syndrome linked to chromosome 1p (RSMD1). Neuromuscul Disord 2002, 12(7-8):631-638.
23. Mercuri E., Bushby K., Ricci E., et al. Muscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3 deficiency (LGMD2A) and early contractures. Neuromuscul Disord 2005, 15(2):164-171.
24. van Deutekom J.C., Janson A.A., Ginjaar I.B., et al. Local dystrophin restoration with antisense oligonucleotide PRO051. NEngl J Med 2007, 357(26):2677-2686.
25. Garrood P., Hollingsworth K.G., Eagle M., et al. MR imaging in Duchenne muscular dystrophy: quantification of T1-weighted signal, contrast uptake, and the effects of exercise. JMagn Reson Imaging 2009, 30(5):1130-1138.
26. Amthor H., Egelhof T., McKinnell I., et al. Albumin targeting of damaged muscle fibres in the mdx mouse can be monitored by MRI. Neuromuscul Disord 2004, 14(12):791-796.
27. Thibaud J.L., Monnet A., Bertoldi D., et al. Characterization of dystrophic muscle in golden retriever muscular dystrophy dogs by nuclear magnetic resonance imaging. Neuromuscul Disord 2007, 17(7):575-584.
28. Mathur S., Lott D.J., Senesac C., et al. Age-related differences in lower-limb muscle cross-sectional area and torque production in boys with Duchenne muscular dystrophy. Arch Phys Med Rehabil 2010, 91(7):1051-1058.
29. Akima H., Lott D., Senesac C., et al. Relationships of thigh muscle contractile and non-contractile tissue with function, strength, and age in boys with Duchenne muscular dystrophy. Neuromuscul Disord 2011, [Epub ahead of print].
30. Kim H.K., Laor T., Horn P.S., et al. T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments. Radiology 2010, 255(3):899-908.
31. Dixon W.T. Simple proton spectroscopic imaging. Radiology 1984, 153(1):189-194.
32. Glover G.H., Schneider E. Three-point Dixon technique for true water/fat decomposition with B0 inhomogeneity correction. Magn Reson Med 1991, 18(2):371-383.
33. Wren T.A., Bluml S., Tseng-Ong L., et al. Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. AJR Am J Roentgenol 2008, 190(1):W8-W12.
34. Kan H.E., Klomp D.W., Wong C.S., et al. Invivo 31P MRS detection of an alkaline inorganic phosphate pool with short T1 in human resting skeletal muscle. NMR Biomed 2010, 23(8):995-1000.
35. Torriani M., Townsend E., Thomas B.J., et al. Lower leg muscle involvement in Duchenne muscular dystrophy: an MR imaging and spectroscopy study. Skeletal Radiol 2011, [Epub ahead of print].
36. Hsieh T.J., Jaw T.S., Chuang H.Y., et al. Muscle metabolism in Duchenne muscular dystrophy assessed by invivo proton magnetic resonance spectroscopy. JComput Assist Tomogr 2009, 33(1):150-154.
37. Kinali M., Arechavala-Gomeza V., Cirak S., et al. Muscle histology vs MRI in Duchenne muscular dystrophy. Neurology 2011, 76(4):346-353.
38. Mavrogeni S., Papavasiliou A., Douskou M., et al. Effect of deflazacort on cardiac and sternocleidomastoid muscles in Duchenne muscular dystrophy: a magnetic resonance imaging study. Eur J Paediatr Neurol 2009, 13(1):34-40.
39. Wagner K.R., Fleckenstein J.L., Amato A.A., et al. Aphase I/IItrial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol 2008, 63(5):561-571.
40. Miller R.G., Sharma K.R., Pavlath G.K., et al. Myoblast implantation in Duchenne muscular dystrophy: the San Francisco study. Muscle Nerve 1997, 20(4):469-478.